United States to start campaign to apply third dose of coronavirus vaccine on September 20

The United States will begin offering a third booster dose of coronavirus vaccines starting September 20., as announced Wednesday by senior US health officials.

In a joint statement from leading medical and public health experts, Joe Biden’s government confirmed that it was making plans to start offering the booster vaccines for increase immunity against the Delta variant.

The plan, what only applies to Pfizer and Moderna vaccines, provides that all Americans receive a booster dose eight months after receiving the second injection. Biden administration officials also said they hoped a booster vaccine for people who have received Johnson & Johnsonbut they’re still reviewing the data and will announce plans in the coming weeks.

“The available data show very clearly that protection against SARS-CoV-2 infection begins to decline over time after the initial doses of vaccination, and in association with the prevalence of the Delta variant, we are starting to see evidence of less protection against mild infections. and moderate illness “said the statement.

“For this reason, we conclude that a booster injection will be necessary to maximize the protection induced by the vaccine and prolong its durability “, the note continues, signed by eight US health officials, including Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC); Vivek H. Murthy, general surgeon and Anthony S. Fauci, director of the National Institute of Allergies and Infectious Diseases.

The plan is subject to approval by the Food and Drug Administration (FDA), which is expected in the coming weeks, according to the Washington Post.

Pfizer and BioNTech announced on Monday that had submitted the preliminary results of their clinical trials to the US authorities as part of your efforts to have a booster doses of COVID-19 vaccine every 16 years and over.

So far, the Food and Drug Administration (FDA) has cleared the third dose of Pfizer and Moderna for people with weakened immune systemsbecause they did not respond like the general population to vaccines, which is estimated at 3% of the country’s population.

According to data provided by Pfizer on Monday, the booster dose generated “significantly higher neutralizing antibodies” against the parent strain of coronavirus, in addition to the beta and delta variantsthe company said in a statement.

Participants in the clinical trial received a third dose between eight and nine months after the second, specifies the text.

“The data we’ve seen so far suggests that a third dose of our vaccine causes antibody levels that significantly exceed those of the initial two dosesPfizer CEO Albert Bourla said in the statement.

KEEP READING: